OBI — Ondine Biomedical Share News
0.000.00%
Last trade - 00:00
- £29.44m
- £27.44m
- CA$0.64m
RCS - Ondine Biomedical - ECDC report shows rising HAIs and antibiotic use
AnnouncementREG - AIM - AIM Notice - 09/05/2024
AnnouncementREG - Ondine Biomedical - Further Result of Fundraising
AnnouncementREG - Ondine Biomedical - Result of Fundraising
AnnouncementREG - Ondine Biomedical - Ondine announces proposed fundraising
AnnouncementREG - Ondine Biomedical - Related Party Transactions
AnnouncementRCS - Ondine Biomedical - New study confirms nose is key source of infection
AnnouncementREG - Ondine Biomedical - Corporate and Trading Update
AnnouncementRCS - Ondine Biomedical - Steriwave in first Australian hospital
AnnouncementRCS - Ondine Biomedical - 32% Fewer SSIs After Steriwave Replaced Mupirocin
AnnouncementRCS - Ondine Biomedical - Steriwave authorized for use by HCA UK
AnnouncementRCS - Ondine Biomedical - Entry into ICU market expands revenue potential
AnnouncementREG - Ondine Biomedical - Appointment of Interim Chief Financial Officer
AnnouncementREG - Ondine Biomedical - First commercial adoption of Steriwave by the NHS
AnnouncementRCS - Ondine Biomedical - Steriwave study shows 77% drop in antibiotic use
AnnouncementRCS - Ondine Biomedical - Steriwave deploying in eight new sites
AnnouncementRCS - Ondine Biomedical - Ondine starts first UK health economics study
AnnouncementRCS - Ondine Biomedical - Microbiome research supports use of Steriwave
AnnouncementREG - Ondine Biomedical - Grant of Share Options
Announcement